A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?

Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13:1648–1655

Article  CAS  PubMed  Google Scholar 

Barnholtz-Sloan JS, Sloan AE, Davis FG et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 22:2865–2872. https://doi.org/10.1200/JCO.2004.12.149

Article  PubMed  Google Scholar 

Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22:3608–3617

Article  PubMed  Google Scholar 

Wang N, Bertalan MS, Brastianos PK (2018) Leptomeningeal metastasis from systemic cancer: review and update on management. Cancer 124:21–35. https://doi.org/10.1002/cncr.30911

Article  PubMed  Google Scholar 

Schrijver WAME, Suijkerbuijk KPM, Van Gils CH et al (2018) Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis. J Natl Cancer Inst 110:568–580

Article  PubMed  Google Scholar 

Hulsbergen AFC, Claes A, Kavouridis VK et al (2020) Subtype switching in breast cancer brain metastases: a multicenter analysis. Neuro Oncol. https://doi.org/10.1093/neuonc/noaa013

Article  PubMed  PubMed Central  Google Scholar 

Cardoso F, Senkus E, Costa A et al (2018) 4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)†. Ann Oncol 29:1634–1657. https://doi.org/10.1093/annonc/mdy192

Article  CAS  PubMed  Google Scholar 

Lin NU, Borges V, Anders C et al (2020) Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial. J Clin Oncol 38:2610–2619. https://doi.org/10.1200/JCO.20.00775

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pérez-García JM, Batista MV, Cortez P et al (2022) Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial. Neuro Oncol. https://doi.org/10.1093/NEUONC/NOAC144

Article  PubMed Central  Google Scholar 

Brastianos PK, Carter SL, Santagata S et al (2015) Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 5:1164–1177. https://doi.org/10.1158/2159-8290.CD-15-0369

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turashvili G, Brogi E (2017) Tumor heterogeneity in breast cancer. Front Med 4:227. https://doi.org/10.3389/fmed.2017.00227

Article  Google Scholar 

Tarin D (2008) Comparisons of metastases in different organs: biological and clinical implications. Clin Cancer Res 14:1923–1925

Article  PubMed  Google Scholar 

Morgan AJ, Giannoudis A, Palmieri C (2021) The genomic landscape of breast cancer brain metastases: a systematic review. Lancet Oncol. https://doi.org/10.1016/S1470-2045(20)30556-8

Article  PubMed  Google Scholar 

Bertucci F, Ng CKY, Patsouris A et al (2019) Genomic characterization of metastatic breast cancers. Nature 569:560–564. https://doi.org/10.1038/s41586-019-1056-z

Article  CAS  PubMed  Google Scholar 

Angus L, Smid M, Wilting SM et al (2019) The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies. Nat Genet 51:1450–1458. https://doi.org/10.1038/s41588-019-0507-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang RSP, Haberberger J, Mcgregor K et al (2021) Clinicopathologic and genomic landscape of breast carcinoma brain metastases. Oncologist. https://doi.org/10.1002/onco.13855

Article  PubMed  PubMed Central  Google Scholar 

Giannoudis A, Sartori A, Eastoe L et al (2021) Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival. Breast Cancer Res Treat 190:241–253. https://doi.org/10.1007/S10549-021-06364-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Da Silva L, Simpson PT, Smart CE et al (2010) HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Res 12:R46. https://doi.org/10.1186/bcr2603

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wikman H, Lamszus K, Detels N et al (2012) Relevance of PTEN loss in brain metastasis formation in breast cancer patients. Breast Cancer Res 14:R49. https://doi.org/10.1186/BCR3150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JY, Park K, Lim SH et al (2015) Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget 6:43731–43742. https://doi.org/10.18632/oncotarget.6192

Article  PubMed  PubMed Central  Google Scholar 

Bollig-Fischer A, Michelhaugh SK, Wijesinghe P et al (2015) Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics. Oncotarget 6:14614–14624. https://doi.org/10.18632/oncotarget.3786

Article  PubMed  PubMed Central  Google Scholar 

Schrijver WA, Selenica P, Lee JY et al (2018) Mutation profiling of key cancer genes in primary breast cancers and their distant metastases. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-17-2310

Article  PubMed  PubMed Central  Google Scholar 

De Mattos-Arruda L, Ng CKY, Piscuoglio S et al (2018) Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases. Oncotarget 9:20617–20630. https://doi.org/10.18632/oncotarget.25041

Article  PubMed  PubMed Central  Google Scholar 

Tyran M, Carbuccia N, Garnier S et al (2019) A comparison of DNA mutation and copy number profiles of primary breast cancers and paired brain metastases for identifying clinically relevant genetic alterations in brain metastases. Cancers (Basel). https://doi.org/10.3390/CANCERS11050665

Article  PubMed  Google Scholar 

Thulin A, Andersson C, Werner Rönnerman E et al (2021) Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors. Sci Rep 11:23548. https://doi.org/10.1038/s41598-021-02903-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao R, Davis A, McDonald TO et al (2016) Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet 48:1119–1130. https://doi.org/10.1038/ng.3641

Article  CAS  PubMed  PubMed Central  Google Scholar 

Magbanua MJM, Melisko M, Roy R et al (2013) Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. Cancer Res 73:7134–7143. https://doi.org/10.1158/0008-5472.CAN-13-2051

Article  CAS  PubMed  Google Scholar 

De M-A, Mayor R, Ng CKY et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun. https://doi.org/10.1038/ncomms9839

Article  PubMed  PubMed Central  Google Scholar 

White MD, Klein RH, Shaw B et al (2021) Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.20040

Article  PubMed  PubMed Central  Google Scholar 

Fitzpatrick A, Iravani M, Mills A et al (2022) Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis. Clin Cancer Res 28:1180–1191. https://doi.org/10.1158/1078-0432.CCR-21-3017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boire A, Brandsma D, Brastianos PK et al (2019) Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro Oncol 21:571–583. https://doi.org/10.1093/neuonc/noz012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheok SK, Narayan A, Arnal-Estape A et al (2021) Tumor DNA mutations from intraparenchymal brain metastases are detectable in CSF. JCO Precis Oncol. https://doi.org/10.1200/PO.20.00292

Article  PubMed  PubMed Central  Google Scholar 

Lee JH, Menzies AM, Carlino MS et al (2020) Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-3926

Article  PubMed  PubMed Central  Google Scholar 

Pentsova EI, Shah RH, Tang J et al (2016) Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J Clin Oncol 34:2404–2415. https://doi.org/10.1200/JCO.2016.66.6487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma C, Yang X, Xing W et al (2020) Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Thoracic Cancer. https://doi.org/10.1111/1759-7714.13300

Article  PubMed  PubMed Central  Google Scholar 

von Baumgarten L, Kumbrink J, Jung A et al (2020) Therapeutic management of neuro-oncologic patients—potential relevance of CSF liquid biopsy. Theranostics 10:856–866. https://doi.org/10

留言 (0)

沒有登入
gif